Taiwan Bio Therapeutics Co., Ltd (TPEX:6892)
Taiwan · Delayed Price · Currency is TWD 27.00
-0.05 (-0.18%)
Oct 8, 2026, 2:59 PM CST
Taiwan Bio Therapeutics Market Cap
Taiwan Bio Therapeutics has a market cap or net worth of 2.28 billion as of October 9, 2026. It is the 27,802nd most valuable company in the world and the 1,584th biggest in Taiwan. Its market cap has decreased by 11.48% in one year.
Market Cap
2.28B
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#1,584 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since May 13, 2022, Taiwan Bio Therapeutics's market cap has increased from 1.93B to 2.28B, an increase of 18.29%. That is a compound annual growth rate of 3.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 2.28B | -5.26% |
| Dec 31, 2025 | 2.41B | -31.88% |
| Dec 31, 2024 | 3.54B | 103.07% |
| Dec 29, 2023 | 1.74B | 7.86% |
| Dec 30, 2022 | 1.62B | -16.32% |
| May 13, 2022 | 1.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Senhwa Biosciences | 3.03B |
| Chunghwa Chemical Synthesis & Biotech | 2.72B |
| 3D Global Biotech | 2.66B |
| GlycoNex Incorporation | 2.57B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.32B |
| HeXun Biosciences | 2.31B |
| Syngen Biotech | 2.19B |
| Anti-Microbial Savior BioteQ | 1.93B |